Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-070155

Interim CEO & General Counsel gave up 17,701 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 41,668 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2026-06-01 Option exercise +41,668 571,206 D
Vogt Frederick G Interim CEO & General Counsel 2026-06-01 Shares withheld for taxes −17,701 $3.96 $70,096 553,505 D
Derivatives
Vogt Frederick G Interim CEO & General Counsel 2026-06-01 Option exercise · Restricted Stock Units −41,668 125,007 D
Loading xslF345X06/tm2616710-4_4seq1.xml…